Glidewell Laboratories signs AI + Decisioning Contract With Adqura

Tuesday, September 11, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, September 11, 2018 /PRNewswire/ --

Adqura are pleased to announce a new partnership with Glidewell Laboratories,

industry-leading provider of high-quality dental lab products and services, the largest dental lab in the world.

Glidewell have appointed Adqura to deliver an omni-channel customer decisioning and AI solution.

Adqura are a Customer Decisioning

and Artificial Intelligence specialist, they help organizations understand their business and customer needs through the customer journey, processes and interaction development, and works to fulfil those needs through next generation customer decisioning solutions. Put simply, they define, build and support omni-channel and AI capability for corporate businesses, optimizing the usage of and value derived from data driven interactions. They have already delivered a global first Pega omni-channel decisioning program with British Gas (Centrica), and are excited to begin this new venture with Glidewell.

A recent product innovation designed and built by Adqura is called Sophie. Sophie is the Always On Marketing Brain, powered by Pegasystems Marketing Technology. Sophie's pre-configured brain comes with a set of cognitive AI abilities that transform in response to certain experiences and stimuli.

Glidewell will be using Sophie to create in depth understanding and insights in to customer needs and preferences, and to optimize and improve customer experiences such that these insights are actioned in a timely and relevant way in real time and on demand across multiple touchpoints, enabling highly personalized customer engagement.

This is an exciting partnership, offering transformational and unique capabilities.

For more information please contact annette.kerlin@adqura.com or visit http://www.adqura.com/platform/

SOURCE Adqura



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store